To Gain a Better Understanding of the Company, its Product Portfolio and its Management Team, BioAlliance Pharma Organizes a Symposium “Oncology: Key Issues for the Future”

PARIS--(BUSINESS WIRE)--Regulatory News:

BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), a company dedicated to specialty and orphan pharma products in oncology and supportive care, today announced a half-day symposium:

"Oncology: key issues for the future"

On March 20, 2012 (from 9 am to 12 midday)